View Discovery

Clinical Pipeline

Learn more about our pipeline

Trials for Market Approval Download PPT

Optimized Background Regimen (OBR)

Pre-Clinical (GLP)

FNDR-20081
Foundation for Neglected Disease Research
S-004992
Shionogi & Co., Ltd
Faropenem WBA
SPRINT-TB (National University of Singapore)
Gyrase B Inhibitor
Vertex Pharmaceuticals, Incorporated
Quinolone TBK-613
TB Alliance

Phase 1

Contezolid (MRX-4/MRX-1)
MicuRx Pharmaceuticals, Inc.
TBA-354
TB Alliance

Phase 2

Bedaquiline - Delamanid with MBT for MDR
Macozinone (MCZ, PBTZ-169)
Nearmedic Plus LLC
Nitazoxanide
Weill Medical College of Cornell University
Nitzoxanide NZT001 14-day EBA
AZD5847
AstraZeneca
Meropenem / Clavulanate
TASK Foundation NPC, GlaxoSmithKline, University Eduardo Mondlane
Thioridazine
Generic, formerly Novartis